Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
According to Novo Nordisk's latest financial reports the company has C$22.59 Billion in net assets. A companyโs net assets is the sum of its assets minus the sum of its liabilities.